Skip to Content
Merck
CN
All Photos(1)

Documents

115665

Sigma-Aldrich

2-Bromo-4′-methoxyacetophenone

97%

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
ω-Bromo-4-methoxyacetophenone, 4-Methoxyphenacyl bromide
Linear Formula:
CH3OC6H4COCH2Br
CAS Number:
2632-13-5
Molecular Weight:
229.07
Beilstein:
743112
EC Number:
220-118-8
MDL number:
MFCD00000201
UNSPSC Code:
12352100
PubChem Substance ID:
24847233
NACRES:
NA.22

Quality Level

100

Assay

97%

form

solid

mp

69-71 °C (lit.)

storage temp.

2-8°C

SMILES string

COc1ccc(cc1)C(=O)CBr

InChI

1S/C9H9BrO2/c1-12-8-4-2-7(3-5-8)9(11)6-10/h2-5H,6H2,1H3

InChI key

XQJAHBHCLXUGEP-UHFFFAOYSA-N

Gene Information

human ... PTPN6(5777)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

2-Bromo-4′-methoxyacetophenone has been used in the synthesis of light-responsive diblock copolymers containing para-methoxyphenacyl photocleavable side groups.

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H314,H335

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - STOT SE 3

Target Organs

Respiratory system

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis of diblock copolymers bearing p-methoxyphenacyl side groups.
Polym. Chem., 2(10), 2284-2292 (2011)
Guido J Noguera et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 78, 190-197 (2015-07-27)
A set of 4-arylthiazolylhydrazones derived from 1-indanones (TZHs) previously synthesized and assayed against Trypanosoma cruzi, the causative agent of Chagas disease, were explored in terms of conformational analysis. We found that TZHs can adopt four minimum energy conformations: cis (A
Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service